Abstract
Because specific approaches for the inhibition or modulation of the cancer cell are lacking, therapies are used that adversely affect some normal cells as well as tumor cells. These treatments make use of highly cytotoxic antibiotics such as daunomycin and actinomycin D, and of cytotoxic antimetabolites such as methotrexate and araC. The agents are employed at maximally tolerated doses in order to remove the greatest possible number of tumor cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
A. Bloch, Antimetabolites in Cancer Chemotherapy: Past, Present and Future, in: “Antimetabolites in Biochemistry, Biology, and Medicine,” J. Skoda and P. Langen, eds., Pergamon Press, New York (1979).
A. Bloch, Purine and Pyrimidine Analogs in Cancer Chemotherapy, in: “New Leads in Cancer Therapeutics,” E. Mihich, ed., GK Hall and Co., Boston (1981).
H. Hozumi, Y. Honma, M. Tomida, J. Okabe, T. Kasukabe, K. Sugiyama, M. Hayashi, K. Takenaga, and Y. Yamamoto, Induction of Differentiation of Myeloid Leukemia Cells with Various Chemicals, Acta Haematol. Japn. 42: 941 (1979).
S. J. Friedman and P. Skehan, Morphological Differentiation of Human Choriocarcinoma Cells Induced by Methotrexate, Cancer Res. 39: 1960 (1979).
S. J. Collins, A. Bodner, R. Ting, and R. C. Gallo, Induction of Morphological and Functional Differentiation of Human Promyelocytic Leukemia cells (HL-60) by Compounds which Induce Differentiation of Murine Leukemia Cells, Int. J. Cancer 25: 213 (1980).
J. Lotem and L. Sachs, Potential Pre-screening for Therapeutic Agents that Induce Differentiation in Human Myeloid Leukemia Cells, Int. J. Cancer 25: 561 (1980).
R. J. Papac, A. E. Brown, E. L. Schwartz, and A. C. Sartorelli, Differentiation of Human Promyelocytic Leukemia Cells In Vitro by 6-Thioguanine, Cancer Lett. 10: 33 (1980).
A. J. Bodner, R. C. Ting, and R. C. Gallo, Induction of Differentiation-associated Characteristics in ML-1, a Line of Human Promyelocytic Leukemia Cells (HL-60) by Nucleosides and Methotrexate, J. Nat. Cancer Inst. 67: 1025 (1981).
D. Schubert and F. Jacob, 5-Bromodeoxyuridine-induced Differentiation of a Neuroblastoma, Proc. Natl. Acad. Sci. U.S.A. 67: 247 (1970).
S. W. Silbert and M. N. Goldstein, Drug-induced Differentiation of a Rat Glioma In Vitro, Cancer Res. 32: 1422 (1972).
K. Takeda, J. Minowada, and A. Bloch, The Role of Drug-induced Differentiation in the Control of Tumor Growth, in: “Proceedings of the 9th International Symposium on the Biologic Characterization of Human Tumors, Bologna, 1981,” Akademie Verlag, Berlin (1983).
K. Takeda, J. Minowada, and A. Bloch, Kinetics of Appearance of Differentiation-associated Characteristics in ML-1, a Line of Human Myeloblastic Leukemia Cells, after Treatment with 12–0-Tetradecanoylphorbol-13-acetate, Dimethyl Sulfoxide, or 1-ß-D-Arabinofuranosylcytosine, Cancer Res. 42: 5152 (1982).
K. Takeda, J. Minowada, and A. Bloch, Differential Ability of Mitogenstimulated Human Leukocyte-conditioned Media to Fc Receptors in Human Leukemia Cells, Cell. Immun. 79: 288 (1983).
A. Bloch, Dependence of Antineoplastic Drug-induced Leukemic Cell Differentiation on the Presence of Natural Differentiation Factors, Cancer Res., in press (1986).
R. W. Craig, O. S. Frankfurt, H. Sakagami, K. Takeda, and A. Bloch, Macromolecular and Cell Cycle Effects of Different Classes of Agents Inducing the Maturation of Human Myeloblastic Leukemia (ML-1) Cells, Cancer Res. 44: 2421 (1984).
Y. Honma, C. Honma, and A. Bloch, Mechanism of Interaction between Antineoplastic Agents and Natural Differentiation Factors in the Induction of Leukemic Cell Maturation, submitted for publication (1986).
A. Bloch, Induced Cell Differentiation in Cancer Therapy, Cancer Treat. Rep. 68: 199 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bloch, A. (1987). Antineoplastic Agents and Cancer Cell Differentiation. In: Cory, J.G., Szentivanyi, A. (eds) Cancer Biology and Therapeutics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9564-6_15
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9564-6_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9566-0
Online ISBN: 978-1-4757-9564-6
eBook Packages: Springer Book Archive